Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Pierre Renard

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Concepts & Ideas

Living Beings

Chemicals & Drugs

Genes & Molecular Sequences

Molecular Structure

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Sohn Kyung-Ah Kim; Cruciani-Guglielmacci Céline; Kassis Nadim; Clément Laurence; Ouali Fetta; Caüzac Michèle; Lebègue Nicolas; Berthelot Pascal; Caignard Daniel-Henri; Pégorier Jean-Paul; Renard Pierre; Dacquet Catherine; Ktorza Alain; Magnan Christophe;
S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
Gallet Sebastien; Flouquet Nathalie; Carato Pascal; Pfeiffer Bruno; Renard Pierre; Léonce Stéphane; Pierré Alain; Berthelot Pascal; Lebegue Nicolas
Benzopyridooxathiazepine derivatives as novel potent antimitotic agents.
Poissonnier-Durieux Sophie; Ettaoussi Mohamed; Pérès Basile; Boutin Jean A; Audinot Valérie; Bennejean Caroline; Delagrange Philippe; Caignard Daniel Henri; Renard Pierre; Berthelot Pascal; Lesieur Daniel; Yous Saïd
Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Pierre Renard (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Sohn Kyung-Ah Kim; Cruciani-Guglielmacci Céline; Kassis Nadim; Clément Laurence; Ouali Fetta; Caüzac Michèle; Lebègue Nicolas; Berthelot Pascal; Caignard Daniel-Henri; Pégorier Jean-Paul; Renard Pierre; Dacquet Catherine; Ktorza Alain; Magnan Christophe;
S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
European journal of pharmacology 2009;608(1-3):104-11.
2009: Gallet Sebastien; Flouquet Nathalie; Carato Pascal; Pfeiffer Bruno; Renard Pierre; Léonce Stéphane; Pierré Alain; Berthelot Pascal; Lebegue Nicolas
Benzopyridooxathiazepine derivatives as novel potent antimitotic agents.
Bioorganic & medicinal chemistry 2009;17(3):1132-8.
2008: Poissonnier-Durieux Sophie; Ettaoussi Mohamed; Pérès Basile; Boutin Jean A; Audinot Valérie; Bennejean Caroline; Delagrange Philippe; Caignard Daniel Henri; Renard Pierre; Berthelot Pascal; Lesieur Daniel; Yous Saïd
Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.
Bioorganic & medicinal chemistry 2008;16(18):8339-48.
2008: Leprince Jérôme; Chatenet David; Dubessy Christophe; Fournier Alain; Pfeiffer Bruno; Scalbert Elizabeth; Renard Pierre; Pacaud Pierre; Oulyadi Hassan; Ségalas-Milazzo Isabelle; Guilhaudis Laure; Davoust Daniel; Tonon Marie-Christine; Vaudry Hubert
Structure-activity relationships of urotensin II and URP.
Peptides 2008;29(5):658-73.
2007: Carmona Maria Carmen; Louche Katie; Lefebvre Bruno; Pilon Antoine; Hennuyer Nathalie; Audinot-Bouchez Véronique; Fievet Catherine; Torpier Gérard; Formstecher Pierre; Renard Pierre; Lefebvre Philippe; Dacquet Catherine; Staels Bart; Casteilla Louis; Pénicaud Luc;
S 26948: a new specific peroxisome proliferator activated receptor gamma modulator with potent antidiabetes and antiatherogenic effects.
Diabetes 2007;56(11):2797-808.
2006: Chatenet David; Dubessy Christophe; Boularan Cédric; Scalbert Elizabeth; Pfeiffer Bruno; Renard Pierre; Lihrmann Isabelle; Pacaud Pierre; Tonon Marie-Christine; Vaudry Hubert; Leprince Jérôme
Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist.
Journal of medicinal chemistry 2006;49(24):7234-8.
2006: Crane Louis; Anastassiadou Maria; El Hage Salomé; Stigliani Jean Luc; Baziard-Mouysset Geneviève; Payard Marc; Leger Jean Michel; Bizot-Espiard Jean-Guy; Ktorza Alain; Caignard Daniel-Henri; Renard Pierre
Design and synthesis of novel imidazoline derivatives with potent antihyperglycemic activity in a rat model of type 2 diabetes.
Bioorganic & medicinal chemistry 2006;14(22):7419-33.
2006: Blanc-Delmas Elodie; Lebegue Nicolas; Wallez Valérie; Leclerc Véronique; Yous Saïd; Carato Pascal; Farce Amaury; Bennejean Caroline; Renard Pierre; Caignard Daniel-Henri; Audinot-Bouchez Valérie; Chomarat Pascale; Boutin Jean; Hennuyer Nathalie; Louche Katie; Carmona Maria Carmen; Staels Bart; Pénicaud Luc; Casteilla Louis; Lonchampt Michel; Dacquet Catherine; Chavatte Philippe; Berthelot Pascal; Lesieur Daniel
Novel 1,3-dicarbonyl compounds having 2(3H)-benzazolonic heterocycles as PPARgamma agonists.
Bioorganic & medicinal chemistry 2006;14(22):7377-91.
2006: Basséne Carine Ekambomé; Suzenet Franck; Hennuyer Nathalie; Staels Bart; Caignard Daniel-Henri; Dacquet Catherine; Renard Pierre; Guillaumet Gérald
Studies towards the conception of new selective PPARbeta/delta ligands.
Bioorganic & medicinal chemistry letters 2006;16(17):4528-32.
2006: Guillaumel Jean; Léonce Stéphane; Pierré Alain; Renard Pierre; Pfeiffer Bruno; Arimondo Paola B; Monneret Claude
Synthesis and biological activity of 6H-isoindolo[2,1-a]indol-6-ones, analogues of batracylin, and related compounds.
European journal of medicinal chemistry 2006;41(3):379-86.
2005: Lebegue Nicolas; Gallet Sebastien; Flouquet Nathalie; Carato Pascal; Pfeiffer Bruno; Renard Pierre; Léonce Stéphane; Pierré Alain; Chavatte Philippe; Berthelot Pascal
Novel benzopyridothiadiazepines as potential active antitumor agents.
Journal of medicinal chemistry 2005;48(23):7363-73.
2005: Caijo Frédéric; Mosset Paul; Grée René; Audinot-Bouchez Valérie; Boutin Jean; Renard Pierre; Caignard Daniel-Henri; Dacquet Catherine
Synthesis of new carbo- and heterocyclic analogues of 8-HETE and evaluation of their activity towards the PPARs.
Bioorganic & medicinal chemistry letters 2005;15(20):4421-6.
2005: Carmona M C; Louche K; Nibbelink M; Prunet B; Bross A; Desbazeille M; Dacquet C; Renard P; Casteilla L; Pénicaud L
Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
International journal of obesity (2005) 2005;29(7):864-71.
2005: Duca Maria; Guianvarc'h Dominique; Meresse Philippe; Bertounesque Emmanuel; Dauzonne Daniel; Kraus-Berthier Laurence; Thirot Sylvie; Léonce Stéphane; Pierré Alain; Pfeiffer Bruno; Renard Pierre; Arimondo Paola B; Monneret Claude
Synthesis and biological study of a new series of 4'-demethylepipodophyllotoxin derivatives.
Journal of medicinal chemistry 2005;48(2):593-603.
2004: Chabane Hadjila; Pierre Alain; Leonce Stephane; Pfeiffer Bruno; Renard Pierre; Thiery Valerie; Guillaumet Gerald; Besson Thierry
Synthesis and cytotoxic activity of thiazolofluorenone derivatives.
Journal of enzyme inhibition and medicinal chemistry 2004;19(6):567-75.
2004: Claret Marc; Corominola Helena; Canals Ignasi; Nadal Belén; Chavanieu Alain; Pfeiffer Bruno; Renard Pierre; Gorostiaga Carmen; Delagrange Philippe; Grassy Gérard; Gomis Ramon
S 23521 decreases food intake and body weight gain in diet-induced obese rats.
Obesity research 2004;12(10):1596-603.
2004: Chatenet David; Dubessy Christophe; Leprince Jérôme; Boularan Cédric; Carlier Ludovic; Ségalas-Milazzo Isabelle; Guilhaudis Laure; Oulyadi Hassan; Davoust Daniel; Scalbert Elizabeth; Pfeiffer Bruno; Renard Pierre; Tonon Marie-Christine; Lihrmann Isabelle; Pacaud Pierre; Vaudry Hubert
Structure-activity relationships and structural conformation of a novel urotensin II-related peptide.
Peptides 2004;25(10):1819-30.
2004: Larraya Carlos; Guillard Jérôme; Renard Pierre; Audinot Valérie; Boutin Jean A; Delagrange Philippe; Bennejean Caroline; Viaud-Massuard Marie-Claude
Preparation of 4-azaindole and 7-azaindole dimers with a bisalkoxyalkyl spacer in order to preferentially target melatonin MT1 receptors over melatonin MT2 receptors.
European journal of medicinal chemistry 2004;39(6):515-26.
2004: Sarrauste de Menthière Cyril; Chavanieu Alain; Grassy Gérard; Dalle Stéphane; Salazar Guillermo; Kervran Alain; Pfeiffer Bruno; Renard Pierre; Delagrange Philippe; Manechez Dominique; Bakes David; Ktorza Alain; Calas Bernard
Structural requirements of the N-terminal region of GLP-1-[7-37]-NH2 for receptor interaction and cAMP production.
European journal of medicinal chemistry 2004;39(6):473-80.
2004: Alagille David; Pfeiffer Bruno; Scalbert Elizabeth; Ferry Gilles; Boutin Jean A; Renard Pierre; Viaud-Massuard Marie-Claude
Design and synthesis of indole and tetrahydroisoquinoline hydantoin derivatives as human chymase inhibitors.
Journal of enzyme inhibition and medicinal chemistry 2004;19(2):137-43.
2004: Guianvarc'h Dominique; Duca Maria; Boukarim Chawki; Kraus-Berthier Laurence; Léonce Stéphane; Pierré Alain; Pfeiffer Bruno; Renard Pierre; Arimondo Paola B; Monneret Claude; Dauzonne Daniel
Synthesis and biological activity of sulfonamide derivatives of epipodophyllotoxin.
Journal of medicinal chemistry 2004;47(9):2365-74.
2004: Lisowski Vincent; Léonce Stéphane; Kraus-Berthier Laurence; Sopková-de Oliveira Santos Jana; Pierré Alain; Atassi Ghanem; Caignard Daniel-Henri; Renard Pierre; Rault Sylvain
Design, synthesis, and evaluation of novel thienopyrrolizinones as antitubulin agents.
Journal of medicinal chemistry 2004;47(6):1448-64.
2004: Doan Thi Mai Huong; Gaslonde Thomas; Michel Sylvie; Koch Michel; Tillequin François; Pfeiffer Bruno; Renard Pierre; Kraus-Berthier Laurence; Léonce Stéphane; Pierré Alain
Synthesis and cytotoxic and antitumor activity of 1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine diacid hemiesters and carbamates.
Chemical & pharmaceutical bulletin 2004;52(3):293-7.
2004: Inguimbert N; Poras H; Dhotel H; Beslot F; Scalbert E; Bennejean C; Renard P; Fournié-Zaluski M-C; Roques B-P
In vivo properties of thiol inhibitors of the three vasopeptidases NEP, ACE and ECE are improved by introduction of a 7-azatryptophan in P2' position.
The journal of peptide research : official journal of the American Peptide Society 2004;63(2):99-107.
2004: Blanchard Stéphanie; Rodriguez Ivan; Tardy Christelle; Baldeyrou Brigitte; Bailly Christian; Colson Pierre; Houssier Claude; Léonce Stéphane; Kraus-Berthier Laurence; Pfeiffer Bruno; Renard Pierre; Pierré Alain; Caubère Paul; Guillaumet Gérald
Synthesis of mono- and bisdihydrodipyridopyrazines and assessment of their DNA binding and cytotoxic properties.
Journal of medicinal chemistry 2004;47(4):978-87.
2004: Mailliet François; Audinot Valérie; Malpaux Benoit; Bonnaud Anne; Delagrange Philippe; Migaud Martine; Barrett Perry; Viaud-Massuard Marie-Claude; Lesieur Daniel; Lefoulon François; Renard Pierre; Boutin Jean A
Molecular pharmacology of the ovine melatonin receptor: comparison with recombinant human MT1 and MT2 receptors.
Biochemical pharmacology 2004;67(4):667-77.
2004: Ferry Gilles; Ubeaud Caroline; Mozo Julien; Péan Christophe; Hennig Philippe; Rodriguez Marianne; Scoul Catherine; Bonnaud Anne; Nosjean Olivier; Galizzi Jean-Pierre; Delagrange Philippe; Renard Pierre; Volland Jean-Paul; Yous Said; Lesieur Daniel; Boutin Jean A
New substrate analogues of human serotonin N-acetyltransferase produce in situ specific and potent inhibitors.
European journal of biochemistry / FEBS 2004;271(2):418-28.
2003: Prunet-Marcassus Bénédicte; Desbazeille Mathieu; Bros Arnaud; Louche Katie; Delagrange Philippe; Renard Pierre; Casteilla Louis; Pénicaud Luc
Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity.
Endocrinology 2003;144(12):5347-52.
2003: Thi Mai Huong Doan; Gaslonde Thomas; Michel Sylvie; Tillequin François; Koch Michel; Bongui Jean-Bernard; Elomri Abdelhakim; Seguin Elisabeth; Pfeiffer Bruno; Renard Pierre; David-Cordonnier Marie-Hélène; Laine William; Bailly Christian; Kraus-Berthier Laurence; Léonce Stéphane; Hickman John A; Pierré Alain
Structure-activity relationships and mechanism of action of antitumor benzo[b]pyrano[3,2-h]acridin-7-one acronycine analogues.
Journal of medicinal chemistry 2003;46(14):3072-82.
2003: Braud Emmanuelle; Duflos Muriel; Le Baut Guillaume; Renard Pierre; Pfeiffer Bruno; Tucker Gordon
Potential inhibitors of angiogenesis. Part II: 3-(azolylmethylene)-2,3-dihydrobenzo[b]furan-2-ones.
Journal of enzyme inhibition and medicinal chemistry 2003;18(3):253-7.
2003: Braud Emmanuelle; Duflos Muriel; Nourrisson Marie-Renee; Tonnerre Alain; Picot Carine; Le Baut Guillaume; Renard Pierre; Pfeiffer Bruno; Tucker Gordon
Potential inhibitors of angiogenesis. Part I: 3-(imidazol-4(5)-ylmethylene)indolin-2-ones.
Journal of enzyme inhibition and medicinal chemistry 2003;18(3):243-52.
2003: Audinot Valérie; Mailliet François; Lahaye-Brasseur Chantal; Bonnaud Anne; Le Gall Aude; Amossé Christophe; Dromaint Sandra; Rodriguez Marianne; Nagel Nadine; Galizzi Jean-Pierre; Malpaux Benoît; Guillaumet Gérald; Lesieur Daniel; Lefoulon François; Renard Pierre; Delagrange Philippe; Boutin Jean A
New selective ligands of human cloned melatonin MT1 and MT2 receptors.
Naunyn-Schmiedeberg's archives of pharmacology 2003;367(6):553-61.
2003: Touzeau Frédérique; Arrault Axelle; Guillaumet Gérald; Scalbert Elizabeth; Pfeiffer Bruno; Rettori Marie-Claire; Renard Pierre; Mérour Jean-Yves
Synthesis and biological evaluation of new 2-(4,5-dihydro-1H-imidazol-2-yl)-3,4-dihydro-2H-1,4-benzoxazine derivatives.
Journal of medicinal chemistry 2003;46(10):1962-79.
2003: Charton Isabelle; Suzenet Franck; Boutin Jean A; Audinot Valérie; Delagrange Philippe; Bennejean Caroline; Renard Pierre; Guillaumet Gérald
Synthesis of 5-substituted-2,3-dihydro-1,4-benzoxathiins: biological evaluation as melatonin receptors ligands.
Journal of enzyme inhibition and medicinal chemistry 2003;18(2):187-93.
2003: Chabane Hadjila; Lamazzi Christelle; Thiery Valerie; Pierre Alain; Leonce Stephane; Pfeiffer Bruno; Renard Pierre; Guillaumet Gérald; Besson Thierry
Synthesis and cytotoxic evaluation of novel thiazolocarbazoles. Part III.
Journal of enzyme inhibition and medicinal chemistry 2003;18(2):167-74.
2003: Mesangeau C; Yous S; Chavatte P; Ferry G; Audinot V; Boutin J A; Delagrange P; Bennejean C; Renard P; Lesieur D
Design, synthesis and in vitro evaluation of novel benzo[b]thiophene derivatives as serotonin N-acetyltransferase (AANAT) inhibitors.
Journal of enzyme inhibition and medicinal chemistry 2003;18(2):119-25.
2003: Labarrère Patricia; Chatenet David; Leprince Jérôme; Marionneau Céline; Loirand Gervaise; Tonon Marie-Christine; Dubessy Christophe; Scalbert Elizabeth; Pfeiffer Bruno; Renard Pierre; Calas Bernard; Pacaud Pierre; Vaudry Hubert
Structure-activity relationships of human urotensin II and related analogues on rat aortic ring contraction.
Journal of enzyme inhibition and medicinal chemistry 2003;18(2):77-88.
2003: Delagrange P; Atkinson J; Boutin J A; Casteilla L; Lesieur D; Misslin R; Pellissier S; Pénicaud L; Renard P
Therapeutic perspectives for melatonin agonists and antagonists.
Journal of neuroendocrinology 2003;15(4):442-8.
2003: Descamps-François Carole; Yous Saïd; Chavatte Philippe; Audinot Valérie; Bonnaud Anne; Boutin Jean A; Delagrange Philippe; Bennejean Caroline; Renard Pierre; Lesieur Daniel
Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands.
Journal of medicinal chemistry 2003;46(7):1127-9.
2003: Angenault Stéphane; Thirot Sylvie; Schmidt Frédéric; Monneret Claude; Pfeiffer Bruno; Renard Pierre
Cancer chemotherapy: a SN-38 (7-ethyl-10-hydroxycamptothecin) glucuronide prodrug for treatment by a PMT (Prodrug MonoTherapy) strategy.
Bioorganic & medicinal chemistry letters 2003;13(5):947-50.
2003: Li Ying; Wu Jin Ming; Shan Feng; Wu Guang Shao; Ding Jian; Xiao Dong; Han Jia Xian; Atassi Ghanem; Leonce Stéphane; Caignard Daniel Henri; Renard Pierre
Synthesis and cytotoxicity of dihydroartemisinin ethers containing cyanoarylmethyl group.
Bioorganic & medicinal chemistry 2003;11(6):977-84.
2003: Yous Saíd; Durieux-Poissonnier Sophie; Lipka-Belloli Emmanuelle; Guelzim Halim; Bochu Christophe; Audinot Valérie; Boutin Jean A; Delagrange Philippe; Bennejean Caroline; Renard Pierre; Lesieur Daniel
Design and synthesis of 3-phenyl tetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands.
Bioorganic & medicinal chemistry 2003;11(5):753-9.
2003: Hinschberger Antoine; Butt Sabrina; Lelong Véronique; Boulouard Michel; Dumuis Aline; Dauphin François; Bureau Ronan; Pfeiffer Bruno; Renard Pierre; Rault Sylvain
New benzo[h][1,6]naphthyridine and azepino[3,2-c]quinoline derivatives as selective antagonists of 5-HT4 receptors: binding profile and pharmacological characterization.
Journal of medicinal chemistry 2003;46(1):138-47.
2003: Guillaumel Jean; Léonce Stéphane; Pierré Alain; Renard Pierre; Pfeiffer Bruno; Peruchon Laure; Arimondo Paola B; Monneret Claude
Synthesis and antiproliferative activity of basic ethers of 1,2-dihydropyrrolo[1,2-a]indole, 6H-isoindolo[2,1-a]indole, and 6H-benz[5,6]isoindolo[2,1-a]indole.
Oncology research 2003;13(12):537-49.
2003: Costes Nadine; Elomri Abdelhakim; Dufat Hanh; Michel Sylvie; Seguin Elisabeth; Koch Michel; Tillequin François; Pfeiffer Bruno; Renard Pierre; Léonce Stéphane; Pierré Alain
Synthesis of 6-dialkylaminoalkylamino pyrano[2,3-c]acridones and benzo[b]pyrano[3,2-h]acridones: soluble acronycine analogues with increased cytotoxic activity.
Oncology research 2003;13(4):191-7.
2002: Wielgosz-Collin Gaetane; Duflos Muriel; Pinson Patricia; Le Baut Guillaume; Renard Pierre; Bennejean Caroline; Boutin Jean; Boulanger Michele
8-Amino-5-nitro-6-phenoxyquinolines: potential non-peptidic neuropeptide Y receptor ligands.
Journal of enzyme inhibition and medicinal chemistry 2002;17(6):449-53.
2002: Lisowski Vincent; Fabis Frédéric; Pierré Alain; Caignard Daniel-Henri; Renard Pierre; Rault Sylvain
Synthesis of new aromatic pyrrolo[2,1-c] [1,4]benzodiazepines and pyrrolo[1,2-a]thieno[3,2-e] [1,4]diazepines as anti-tumoral agents.
Journal of enzyme inhibition and medicinal chemistry 2002;17(6):403-7.
2002: Lamazzi Christelle; Chabane Hadjila; Thiery Valerie; Pierre Alain; Leonce Stephane; Pfeiffer Bruno; Renard Pierre; Guillaumet Gérald; Besson Thierry
Synthesis and cytotoxic evaluation of novel thiazolocarbazoles.
Journal of enzyme inhibition and medicinal chemistry 2002;17(6):397-401.
2002: Inguimbert Nicolas; Poras Hervé; Teffo Franck; Beslot Françoise; Selkti Mohamed; Tomas Alain; Scalbert Elizabeth; Bennejean Caroline; Renard Pierre; Fournié-Zaluski Marie-Claude; Roques Bernard-Pierre
N-[2-(Indan-1-yl)-3-mercapto-propionyl] amino acids as highly potent inhibitors of the three vasopeptidases (NEP, ACE, ECE): In vitro and In vivo activities.
Bioorganic & medicinal chemistry letters 2002;12(15):2001-5.
2002: Roulland Emmanuel; Monneret Claude; Florent Jean-Claude; Bennejean Caroline; Renard Pierre; Léonce Stéphane
Enantioselective synthesis of 12-amino alkylidenecyclopentenone prostaglandins.
The Journal of organic chemistry 2002;67(13):4399-406.
2002: Wallez Valérie; Durieux-Poissonnier Sophie; Chavatte Philippe; Boutin Jean A; Audinot Valérie; Nicolas Jean-Paul; Bennejean Caroline; Delagrange Philippe; Renard Pierre; Lesieur Daniel
Synthesis and structure-affinity-activity relationships of novel benzofuran derivatives as MT(2) melatonin receptor selective ligands.
Journal of medicinal chemistry 2002;45(13):2788-800.
2002: Leclerc Véronique; Yous Saïd; Delagrange Philippe; Boutin Jean A; Renard Pierre; Lesieur Daniel
Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3).
Journal of medicinal chemistry 2002;45(9):1853-9.
2002: Bruban Véronique; Estato Vanessa; Schann Stephan; Ehrhardt Jean-Daniel; Monassier Laurent; Renard Pierre; Scalbert Elizabeth; Feldman Josiane; Bousquet Pascal
Evidence for synergy between alpha(2)-adrenergic and nonadrenergic mechanisms in central blood pressure regulation.
Circulation 2002;105(9):1116-21.
2001: Thiéry V; Coudert G; Bizot-Espiard J G; Pfeiffer B; Renard P; Lindenbaum A; Guillaumet G
A novel series of 2,6,7-substituted 2,3-dihydro-1,4-benzodioxin and 2,6,7-substituted 1,4-benzodioxin derivatives as lipid peroxidation inhibitors. Structure-activity relationships for high inhibition of human low-density lipoprotein peroxidation.
Journal of medicinal chemistry 2001;44(23):3904-14.
2001: Kostakis I K; Pouli N; Marakos P; Mikros E; Skaltsounis A L; Leonce S; Atassi G; Renard P
Synthesis, cytotoxic activity, NMR study and stereochemical effects of some new pyrano[3,2-b]thioxanthen-6-ones and pyrano[2,3-c]thioxanthen-7-ones.
Bioorganic & medicinal chemistry 2001;9(11):2793-802.
2001: Bongui J B; Elomri A; Seguin E; Tillequin F; Pfeiffer B; Renard P; Pierré A; Atassi G
Synthesis and cytotoxic activity of benzophenanthrolinone analogues of acronycine.
Chemical & pharmaceutical bulletin 2001;49(9):1077-80.
2001: Lisowski V; Enguehard C; Lancelot J; Caignard D; Lambel S; Leonce S; Pierre A; Atassi G; Renard P; Rault S
Design, synthesis and antiproliferative activity of tripentones: a new series of antitubulin agents.
Bioorganic & medicinal chemistry letters 2001;11(16):2205-8.
2001: Rezaie R; Joseph B; Bremner J B; Delagrange P; Kopp C; Misslin R; Pfeiffer B; Renard P; Guillaumet G
5-substituted 3,4-dihydro-3-amino-2H-1-benzopyran derivatives: synthesis and interaction with serotoninergic receptors.
The Journal of pharmacy and pharmacology 2001;53(7):959-68.
2001: Sittisombut C; Costes N; Michel S; Koch M; Tillequin F; Pfeiffer B; Renard P; Pierré A; Atassi G
Synthesis and cytotoxic activity of benzopyranoxanthone analogues of benz.
Chemical & pharmaceutical bulletin 2001;49(6):675-9.
2001: Wu J M; Shan F; Wu G S; Li Y; Ding J; Xiao D; Han J X; Atassi G; Leonce S; Caignard D H; Renard P
Synthesis and cytotoxicity of artemisinin derivatives containing cyanoarylmethyl group.
European journal of medicinal chemistry 2001;36(5):469-79.
2001: Bruban V; Feldman J; Greney H; Dontenwill M; Schann S; Jarry C; Payard M; Boutin J; Scalbert E; Pfeiffer B; Renard P; Vanhoutte P; Bousquet P
Respective contributions of alpha-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugs.
British journal of pharmacology 2001;133(2):261-6.
2001: Schann S; Bruban V; Pompermayer K; Feldman J; Pfeiffer B; Renard P; Scalbert E; Bousquet P; Ehrhardt J D
Synthesis and biological evaluation of pyrrolinic isosteres of rilmenidine. Discovery of cis-/trans-dicyclopropylmethyl-(4,5-dimethyl-4,5-dihydro-3H-pyrrol-2-yl)-amine (LNP 509), an I1 imidazoline receptor selective ligand with hypotensive activity.
Journal of medicinal chemistry 2001;44(10):1588-93.
2001: Melliou E; Magiatis P; Mitaku S; Skaltsounis A L; Pierré A; Atassi G; Renard P
2,2-Dimethyl-2H-anthra[2,3-b]pyran-6,11-diones: a new class of cytotoxic compounds.
Bioorganic & medicinal chemistry 2001;9(3):607-12.
2001: Anastassiadou M; Danoun S; Crane L; Baziard-Mouysset G; Payard M; Caignard D H; Rettori M C; Renard P
Synthesis and pharmacological evaluation of imidazoline sites I1 and I2 selective ligands.
Bioorganic & medicinal chemistry 2001;9(3):585-92.
2001: Baglin I; Daveu C; Lancelot J C; Bureau R; Dauphin F; Pfeiffer B; Renard P; Delagrange P; Rault S
First tricyclic oximino derivatives as 5-HT3 ligands.
Bioorganic & medicinal chemistry letters 2001;11(4):453-7.
2001: Li Y; Shan F; Wu J M; Wu G S; Ding J; Xiao D; Yang W Y; Atassi G; Léonce S; Caignard D H; Renard P
Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle.
Bioorganic & medicinal chemistry letters 2001;11(1):5-8.
2000: Merle A; Faucheron J L; Delagrange P; Renard P; Roche M; Pellissier S
Nycthemeral variations of cholecystokinin action on intestinal motility in rats: effects of melatonin and S 20928, a melatonin receptor antagonist.
Neuropeptides 2000;34(6):385-91.
2000: Graf-Christophe S; Kuehm-Caubère C; Renard P; Pfeiffer B; Pierré A; Léonce S; Caubère P
Synthesis and antiproliferative activity of benzocyclobutacarbazol derivatives. A new class of potential antitumor agents.
Bioorganic & medicinal chemistry letters 2000;10(23):2589-91.
2000: Bénéteau V; Pierré A; Pfeiffer B; Renard P; Besson T
Synthesis and antiproliferative evaluation of 7-aminosubstituted pyrroloiminoquinone derivatives.
Bioorganic & medicinal chemistry letters 2000;10(19):2231-4.
2000: Lamazzi C; Léonce S; Pfeiffer B; Renard P; Guillaumet G; Rees C W; Besson T
Expeditious synthesis and cytotoxic activity of new cyanoindolo[3,2-c]quinolines and benzimidazo[1,2-c]quinazolines.
Bioorganic & medicinal chemistry letters 2000;10(19):2183-5.
2000: Merle A; Delagrange P; Renard P; Lesieur D; Cuber J C; Roche M; Pellissier S
Effect of melatonin on motility pattern of small intestine in rats and its inhibition by melatonin receptor antagonist S 22153.
Journal of pineal research 2000;29(2):116-24.
2000: Costes N; Le Deit H; Michel S; Tillequin F; Koch M; Pfeiffer B; Renard P; Léonce S; Guilbaud N; Kraus-Berthier L; Pierré A; Atassi G
Synthesis and cytotoxic and antitumor activity of benzo[b]pyrano[3, 2-h]acridin-7-one analogues of acronycine.
Journal of medicinal chemistry 2000;43(12):2395-402.
2000: Larget R; Lockhart B; Renard P; Largeron M
A convenient extension of the Wessely-Moser rearrangement for the synthesis of substituted alkylaminoflavones as neuroprotective agents in vitro.
Bioorganic & medicinal chemistry letters 2000;10(8):835-8.
2000: Baurin N; Vangrevelinghe E; Morin-Allory L; Mérour J Y; Renard P; Payard M; Guillaumet G; Marot C
3D-QSAR CoMFA study on imidazolinergic I(2) ligands: a significant model through a combined exploration of structural diversity and methodology.
Journal of medicinal chemistry 2000;43(6):1109-22.
2000: Comoy C; Guérin V; Pfeiffer B; Rettori M C; Renard P; Guillaumet G
Substituted 3-amino and/or 3-aminomethyl-3,4-dihydro-2H-1-benzopyrans: synthesis and biological activity.
Bioorganic & medicinal chemistry 2000;8(3):483-95.
2000: Ferry G; Loynel A; Kucharczyk N; Bertin S; Rodriguez M; Delagrange P; Galizzi J P; Jacoby E; Volland J P; Lesieur D; Renard P; Canet E; Fauchère J L; Boutin J A
Substrate specificity and inhibition studies of human serotonin N-acetyltransferase.
The Journal of biological chemistry 2000;275(12):8794-805.
2000: Duhault J; Boulanger M; Chamorro S; Boutin J A; Della Zuana O; Douillet E; Fauchère J L; Félétou M; Germain M; Husson B; Vega A M; Renard P; Tisserand F
Food intake regulation in rodents: Y5 or Y1 NPY receptors or both?
Canadian journal of physiology and pharmacology 2000;78(2):173-85.
2000: Pégurier C; Curtet S; Nicolas J P; Boutin J A; Delagrange P; Renard P; Langlois M
Synthesis of a small library of phenylalkylamide derivatives as melatoninergic ligands for human mt1 and MT2 receptors.
Bioorganic & medicinal chemistry 2000;8(1):163-71.
2000: Charton I; Mamai A; Bennejean C; Renard P; Howell E H; Guardiola-Lemaître B; Delagrange P; Morgan P J; Viaud M C; Guillaumet G
Substituted oxygenated heterocycles and thio-analogues: synthesis and biological evaluation as melatonin ligands.
Bioorganic & medicinal chemistry 2000;8(1):105-14.
2000: Younes S; Labssita Y; Baziard-Mouysset G; Payard M; Rettori M; Renard P; Pfeiffer B; Caignard D
Synthesis and structure-activity relationships of novel arylalkyl 4-benzyl piperazine derivatives as sigma site selective ligands.
European journal of medicinal chemistry 2000;35(1):107-21.
2000: Boutin J A; Lahaye C; Pegurier C; Nicolas J P; Fauchere J L; Langlois M; Renard P; Delagrange P; Canet E
Screening of ligand binding on melatonin receptor using non-peptide combinatorial libraries.
Journal of receptor and signal transduction research 2000;20(1):105-18.
1999: Kopp C; Vogel E; Rettori M C; Delagrange P; Renard P; Lesieur D; Misslin R
Regulation of emotional behaviour by day length in mice: implication of melatonin.
Behavioural pharmacology 1999;10(8):747-52.
1999: Kopp C; Vogel E; Rettori M C; Delagrange P; Renard P; Lesieur D; Misslin R
Antagonistic effects of S 22153, a new mt1 and MT2 receptor ligand, on the neophobia-reducing properties of melatonin in BALB/c mice.
Pharmacology, biochemistry, and behavior 1999;64(1):131-6.
1999: Catrycke M O; Houssin R; Hénichart J P; Pfeiffer B; Renard P; Dassonneville L; Bailly C
Synthesis and cytotoxicity of analogues of the antibiotic BE 10988 inhibitors of DNA topoisomerase II.
Bioorganic & medicinal chemistry letters 1999;9(14):2025-30.
1999: Pelé-Tounian A; Chan S L; Rondu F; Le Bihan G; Giroix M H; Lamouri A; Touboul E; Pfeiffer B; Manechez D; Renard P; Guardiola-Lemaître B; Godfroid J J; Pénicaud L; Morgan N G; Ktorza A
Effect of the new imidazoline derivative S-22068 (PMS 847) on insulin secretion in vitro and glucose turnover in vivo in rats.
European journal of pharmacology 1999;377(1):81-7.
1999: Le Bihan G; Rondu F; Pelé-Tounian A; Wang X; Lidy S; Touboul E; Lamouri A; Dive G; Huet J; Pfeiffer B; Renard P; Guardiola-Lemaître B; Manéchez D; Pénicaud L; Ktorza A; Godfroid J J
Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-, 1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines and isosteric analogues of imidazoline.
Journal of medicinal chemistry 1999;42(9):1587-603.
1999: Jellimann C; Mathé-Allainmat M; Andrieux J; Renard P; Delagrange P; Langlois M
Melatonergic properties of the (+)- and (-)-enantiomers of N-(4-methoxy-2,3-dihydro-1H-phenalen-2-yl)amide derivatives.
Journal of medicinal chemistry 1999;42(6):1100-5.
1999: Boyé S; Pfeiffer B; Renard P; Rettori M C; Guillaumet G; Viaud M C
N,N-disubstituted aminomethyl benzofuran derivatives: synthesis and preliminary binding evaluation.
Bioorganic & medicinal chemistry 1999;7(2):335-41.
1998: Savelon L; Bizot-Espiard J G; Caignard D H; Pfeiffer B; Renard P; Viaud M C; Guillaumet G
6-aminoalkyloxazolo[4,5-b]pyridin-2(3H)-ones: synthesis and evaluation of antinoceptive activity.
Bioorganic & medicinal chemistry 1998;6(11):1963-73.
1998: Marot C; Chavatte P; Morin-Allory L; Viaud M C; Guillaumet G; Renard P; Lesieur D; Michel A
Pharmacophoric search and 3D-QSAR comparative molecular field analysis studies on agonists of melatonin sheep receptors.
Journal of medicinal chemistry 1998;41(23):4453-65.
1998: Leclerc V; Fourmaintraux E; Depreux P; Lesieur D; Morgan P; Howell H E; Renard P; Caignard D H; Pfeiffer B; Delagrange P; Guardiola-Lemaître B; Andrieux J
Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands.
Bioorganic & medicinal chemistry 1998;6(10):1875-87.
1998: Lesieur D; Leclerc V; Chavatte P; Marot C; Renard P; Guardiola-Lemaitre B
[Melatonin, a pertinent prototype for therapeutic innovation]
Thérapie 1998;53(5):429-37.
1998: Pelé-Tounian A; Wang X; Rondu F; Lamouri A; Touboul E; Marc S; Dokhan R; Pfeiffer B; Manechez D; Renard P; Guardiola-Lemaître B; Godfroid J J; Pénicaud L; Ktorza A
Potent antihyperglycaemic property of a new imidazoline derivative S-22068 (PMS 847) in a rat model of NIDDM.
British journal of pharmacology 1998;124(8):1591-6.
1998: Magiatis P; Melliou E; Skaltsounis A L; Mitaku S; Léonce S; Renard P; Pierré A; Atassi G
Synthesis and cytotoxic activity of pyranocoumarins of the seselin and xanthyletin series.
Journal of natural products 1998;61(8):982-6.
1998: Taverne T; Diouf O; Depreux P; Poupaert J H; Lesieur D; Guardiola-Lemaître B; Renard P; Rettori M C; Caignard D H; Pfeiffer B
Novel benzothiazolin-2-one and benzoxazin-3-one arylpiperazine derivatives with mixed 5HT1A/D2 affinity as potential atypical antipsychotics.
Journal of medicinal chemistry 1998;41(12):2010-8.
1998: Savelon L; Bizot-Espiard J G; Caignard D H; Pfeiffer B; Renard P; Viaud M C; Guillaumet G
Substituted pyrido[3,2-b]oxazin-3(4H)-ones: synthesis and evaluation of antinociceptive activity.
Bioorganic & medicinal chemistry 1998;6(2):133-42.
1998: Razafimbelo J; Baudouin G; Tillequin F; Renard P; Léonce S; Pierré A; Atassi G
Synthesis and cytotoxic activity of pyranophenanthridine analogues of fagaronine and acronycine.
Chemical & pharmaceutical bulletin 1998;46(1):34-41.
1997: Rondu F; Le Bihan G; Wang X; Lamouri A; Touboul E; Dive G; Bellahsene T; Pfeiffer B; Renard P; Guardiola-Lemaitre B; Manechez D; Penicaud L; Ktorza A; Godfroid J J
Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 1. Synthesis and biological activities of N-benzyl-N'-(arylalkyl)-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines .
Journal of medicinal chemistry 1997;40(23):3793-803.
1997: Prunier H; Rault S; Lancelot J C; Robba M; Renard P; Delagrange P; Pfeiffer B; Caignard D H; Misslin R; Guardiola-Lemaitre B; Hamon M
Novel and selective partial agonists of 5-HT3 receptors. 2. Synthesis and biological evaluation of piperazinopyridopyrrolopyrazines, piperazinopyrroloquinoxalines, and piperazinopyridopyrroloquinoxalines.
Journal of medicinal chemistry 1997;40(12):1808-19.
1997: Kuehm-Caubere C; Caubere P; Jamart-Gregoire B; Negre-Salvayre A; Bonnefont-Rousselot D; Bizot-Espiard J G; Pfeiffer B; Caignard D H; Guardiola-Lemaitre B; Renard P
Novel indole-2-carboxamide and cycloalkeno[1,2-b]indole derivatives. Structure-activity relationships for high inhibition of human LDL peroxidation.
Journal of medicinal chemistry 1997;40(8):1201-10.
1996: Delagrange P; Emerit M B; Merahi N; Abraham C; Morain P; Rault S; Renard P; Pfeiffer B; Guardiola-Lemaître B; Hamon M
Interaction of S 21007 with 5-HT3 receptors. In vitro and in vivo characterization.
European journal of pharmacology 1996;316(2-3):195-203.
1996: Comoy C; Marot C; Podona T; Baudin M L; Morin-Allory L; Guillaumet G; Pfeiffer B; Caignard D H; Renard P; Rettori M C; Adam G; Guardiola-Lemaitre B
3-amino-3,4-dihydro-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 2. Synthesis and quantitative structure-activity relationship studies of spiro[pyrrolidine- and piperidine-2,3'(2'H)-benzopyrans]
Journal of medicinal chemistry 1996;39(21):4285-98.
1996: Mathé-Allainmat M; Gaudy F; Sicsic S; Dangy-Caye A L; Shen S; Brémont B; Benatalah Z; Langlois M; Renard P; Delagrange P
Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.
Journal of medicinal chemistry 1996;39(16):3089-95.
1996: Wang X; Rondu F; Lamouri A; Dokhan R; Marc S; Touboul E; Pfeiffer B; Manechez D; Renard P; Guardiola-Lemaitre B; Godfroid J J; Ktorza A; Pénicaud L
Effect of S-21663 (PMS 812), an imidazoline derivative, on glucose tolerance and insulin secretion in a rat model of type II diabetes.
The Journal of pharmacology and experimental therapeutics 1996;278(1):82-9.
1996: Rault S; Lancelot J C; Prunier H; Robba M; Renard P; Delagrange P; Pfeiffer B; Caignard D H; Guardiola-Lemaitre B; Hamon M
Novel selective and partial agonists of 5-HT3 receptors. Part 1. Synthesis and biological evaluation of piperazinopyrrolothienopyrazines.
Journal of medicinal chemistry 1996;39(10):2068-80.
1995: Viaud M C; Jamoneau P; Bizot-Espiard J G; Pfeiffer B; Renard P; Caignard D H; Adam G; Guillaumet G
N-substituted aminohydroxypyridines as potential non-opioid analgesic agents.
Bioorganic & medicinal chemistry 1995;3(7):929-37.
1995: Langlois M; Brémont B; Shen S; Poncet A; Andrieux J; Sicsic S; Serraz I; Mathé-Allainmat M; Renard P; Delagrange P
Design and synthesis of new naphthalenic derivatives as ligands for 2-[125I]iodomelatonin binding sites.
Journal of medicinal chemistry 1995;38(12):2050-60.
1995: Viaud M C; Jamoneau P; Flouzat C; Bizot-Espiard J G; Pfeiffer B; Renard P; Caignard D H; Adam G; Guillaumet G
N-substituted oxazolo[5,4-b]pyridin-2(1H)-ones: a new class of non-opiate antinociceptive agents.
Journal of medicinal chemistry 1995;38(8):1278-86.
1994: Depreux P; Lesieur D; Mansour H A; Morgan P; Howell H E; Renard P; Caignard D H; Pfeiffer B; Delagrange P; Guardiola B
Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands.
Journal of medicinal chemistry 1994;37(20):3231-9.
1994: Podona T; Guardiola-Lemaître B; Caignard D H; Adam G; Pfeiffer B; Renard P; Guillaumet G
3,4-Dihydro-3-amino-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 1. Synthesis and structure--activity relationship studies.
Journal of medicinal chemistry 1994;37(12):1779-93.
1992: Adam G; Guardiola-Lemaitre B; Yous S; Lesieur D; Morgan P; Howell H E; Andrieux J; Caignard D H; Pfeiffer B; Renard P
[New naphthalenic ligands of melatoninergic receptors]
Journal de pharmacie de Belgique 1992;47(4):374-80.
1992: Yous S; Andrieux J; Howell H E; Morgan P J; Renard P; Pfeiffer B; Lesieur D; Guardiola-Lemaitre B
Novel naphthalenic ligands with high affinity for the melatonin receptor.
Journal of medicinal chemistry 1992;35(8):1484-6.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Pierre Renard

Research Profile (preview)

Concepts & Ideas

Living Beings

Chemicals & Drugs

Genes & Molecular Sequences

Procedures

Disorders

Anatomy

Occupations

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Pierre Renard (preview)

All Publications